Trim32 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The TRIM32 gene (Tripartite Motif Containing 32) encodes an E3 ubiquitin ligase protein that plays critical roles in protein quality control, mitochondrial function, and neuronal survival. TRIM32 is located on chromosome 9q33.1 and is expressed ubiquitously with high expression in brain, muscle, and testis. Mutations in TRIM32 cause Bardet-Biedl syndrome, and dysregulation of TRIM32 is implicated in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).
| Attribute | Value |
|---|---|
| Symbol | TRIM32 |
| Full Name | Tripartite Motif Containing 32 |
| Chromosomal Location | 9q33.1 |
| NCBI Gene ID | 22954 |
| Ensembl ID | ENSG00000119431 |
| UniProt | Q9NXK5 |
| Protein Type | E3 Ubiquitin Ligase |
| Molecular Weight | 76 kDa |
TRIM32 belongs to the TRIpartite Motif (TRIM) family of proteins, characterized by:
The PRY-SPRY domain is responsible for substrate specificity, recognizing various target proteins for ubiquitination.
TRIM32 catalyzes the attachment of ubiquitin molecules to target proteins, marking them for:
TRIM32 ubiquitination targets include:
TRIM32 plays a crucial role in maintaining mitochondrial integrity:
TRIM32 is expressed in:
TRIM32 mutations cause BBS11, a ciliopathy characterized by:
TRIM32 involvement in AD:
In PD, TRIM32 may contribute to:
TRIM32 mutations are linked to:
TRIM32 has dual roles in cancer:
TRIM32 interacts with several key pathways:
Trim32 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Trim32 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Meroni G. Tripartite motif proteins and the innate immune response. Trends in Cell Biology. 2019;29(10):759-770. DOI:10.1016/j.tcb.2019.08.005
[2] Bott LC, et al. TRIM32 mutations cause ALS. Acta Neuropathologica Communications. 2020;8(1):26. DOI:10.1186/s40478-020-00979-4
[3] Locke M, et al. TRIM32 mutations and Bardet-Biedl syndrome. Human Molecular Genetics. 2011;20(16):3206-3212.
[4] Nalbandian A, et al. TRIM32 and neurodegeneration. Journal of Molecular Neuroscience. 2015;56(2):289-298.
[5] Zhou X, et al. TRIM32 in mitochondrial quality control. Cell Reports. 2021;35(9):109247.
[6] Chiang AP, et al. Bardet-Biedl syndrome. European Journal of Human Genetics. 2009;17(7):859-868.